{
event: "article_read",
name: `When a Child Gets Autoimmune Type 1 Diabetes`,
author: `Sanofi`,
tags: `Diabète | Diabète De Type 1`,
publication_date: ``,
interaction_type: "content"
}
When a Child Gets Autoimmune Type 1 Diabetes
Author :Sanofi
Editorial Team
Parent's experiences of stage 3 diagnosis of T1D.
Discover the real-life impact of autoimmune Type 1 Diabetes (T1D) through the perspective of Sigurd’s parents. In this testimonial, they share their experiences of missed early signs, the sudden shock of diagnosis, and the profound impact that T1D has had on their family life.
In this testimonial film, Sigurd’s parents reflect on how they overlooked signs of Sigurd developing autoimmune T1D, the moment of realization, the shock of diagnosis, how their lives changed overnight, and what earlier detection could have meant:
Sigurd’s mother speaks candidly about the toll of constant glucose monitoring device alarms and the emotional strain on their other children.
Sigurd’s father shares how his lived experience with autoimmune T1D helped them adapt to Sigurd’s diagnosis. He also shares his opinions about whether he would have wanted to know in advance that Sigurd was developing autoimmune T1D.
Sigurd’s parent's message to healthcare professionals is clear: early detection through autoantibody screening has many benefits. It offers time to prepare, it can support families psychologically, and it can lessen the shock of diagnosis, for everyone whose daily life may be affected by autoimmune T1D.
Part 1: How parents perceive the risk of their child developing autoimmune Type 1 Diabetes
Part 2: What it is like to discover that your child has autoimmune Type 1 Diabetes
Part 3: What it takes to cope with the shock of diagnosis and to adjust to life with autoimmune T1D
Part 4: Whether there is value in knowing early on if a family member is developing autoimmune Type 1 Diabetes
Part 5: Everyday life with autoimmune type 1 diabetes
Full video: When A Child Gets Autoimmune Type 1 Diabetes
Articles liés
Early detection of autoimmune type 1 diabetes could reduce the risk of diabetic ketoacidosis
Delay in screening for autoimmune type 1 diabetes (T1D) can increase the risk of diabetic ketoacidosis (DKA) at diagnosis—a critical complication that is potentially life-threatening and may result in long-term poor glycemic control and neurological complications.1,2 By identifying autoimmune T1D early, you can significantly lower the risk of DKA at diagnosis.3,4
How should individuals with positive autoimmune T1D autoantibodies be monitored over time?
Individuals who screen positive for ≥1 autoimmune islet cell antibodies need periodic medical monitoring, which includes regular assessments of blood glucose and HbA1c levels. You can also educate them about symptoms of diabetes, diabetic ketoacidosis (DKA), and provide psychosocial support to prepare them for a possible clinical diagnosis for type 1 diabetes (T1D).1
Does your patient have an existing autoimmune condition? Check for autoimmune type 1 diabetes!
Individuals living with other associated autoimmune diseases like celiac disease or autoimmune thyroid disease, are at an increased risk of developing autoimmune type 1 diabetes (T1D) and should be appropriately screened.1-6
Les contenus accessibles par ce site sont destinés exclusivement aux Professionnels de Santé.
Les contenus accessibles par ce site sont destinés
exclusivement aux Professionnels de Santé.
Sanofi met a votre disposition, sur un portail unique dédié aux professionnels de santé, des contenus exclusifs comprenant des contenus scientifiques et des outils pour votre pratique quotidienne.